![James Nathanielsz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Nathanielsz
Chief Executive Officer at
PROPANC BIOPHARMA, INC.
Net worth: 276 642 $ as of 31/05/2026
Profile
Mr. James A. Nathanielsz is an Executive Chairman, CEO & Treasurer at Propanc Biopharma, Inc. and a Chief Executive Officer & Director at Propanc Pty Ltd. He is on the Board of Directors at Propanc Pty Ltd. Mr. Nathanielsz was previously employed as a Manager-New Products by Biota Holdings Ltd. He received his undergraduate degree from Swinburne University of Technology and a graduate degree from Swinburne University of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/03/2026 | 152,000 ( 6.67% ) | 276 640 $ | 31/05/2026 | |
| 16/03/2026 | 1 ( 100% ) | 2 $ | 31/05/2026 |
James Nathanielsz active positions
| Companies | Position | Start |
|---|---|---|
| PROPANC BIOPHARMA, INC. | Chief Executive Officer | 15/10/2007 |
Propanc Pty Ltd.
 Propanc Pty Ltd. BiotechnologyHealth Technology Engages in cancer treatment research | Founder | 12/10/2007 |
Former positions of James Nathanielsz
| Companies | Position | End |
|---|---|---|
| BIOTA HOLDINGS LTD. | Corporate Officer/Principal | 01/10/2007 |
Training of James Nathanielsz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Propanc Biopharma, Inc.
 Propanc Biopharma, Inc. BiotechnologyHealth Technology Operates as a development stage healthcare company which develops new cancer treatments for patients | Health Technology |
Biota Holdings Pty Ltd.
 Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as an anti infective drug development company | Health Technology |
Swinburne University of Technology
 Swinburne University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Propanc Pty Ltd.
Propanc Pty Ltd. BiotechnologyHealth Technology Engages in cancer treatment research | Health Technology |
- Stock Market
- Insiders
- James Nathanielsz
